Clinical Trials on Hyperlipoproteinemia Type V
Total 56107 results
-
University of Texas Southwestern Medical CenterRecruitingType 1 HyperlipoprotenemiaUnited States
-
AstraZenecaCompletedHypertriglyceridemia | Hyperlipidemia | Hyperlipoproteinemia Type V | Hyperlipoproteinemia Type IV | Hyperlipoproteinemia Type IIbMexico
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.Withdrawn
-
Brigham and Women's HospitalActive, not recruitingASCVD | Hyperlipemia, MixedUnited States
-
Merck Sharp & Dohme LLCTerminatedHypercholesterolemia | Mixed Hyperlipemia
-
Korea United Pharm. Inc.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed HyperlipemiaChina
-
University of Texas Southwestern Medical CenterTerminatedType 1 HyperlipoproteinemiaUnited States
-
PfizerTerminatedMixed HyperlipidemiaUnited States, Canada, Czech Republic, Finland, France, Netherlands
-
Nina HermansUniversity Hospital, AntwerpRecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaBelgium
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel ScientificCompletedLDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II DiseaseRussian Federation
-
Merck Sharp & Dohme LLCCompletedMixed Hyperlipidemia
-
Sang Hak LeeUnknownMixed HyperlipidemiaKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolemia | Mixed Hyperlipidemia
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolemia | Mixed Hyperlipidemia
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolaemia | Mixed Hyperlipidaemia
-
Hospices Civils de LyonCompleted
-
Technische Universität DresdenKaneka Pharma Europe N.V.RecruitingLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaGermany
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMixed Hyperlipidemia | Non-familial HypercholesterolemiaChina
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Changi General HospitalNot yet recruitingCardiovascular Diseases | Hypercholesterolemia | Lipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaSingapore
-
UniQure Biopharma B.V.CompletedLipoprotein Lipase Deficiency | Familial Hyperlipoproteinemia Type 1 | Familial HyperchylomicronemiaGermany
-
Novartis PharmaceuticalsRecruitingHyperlipoproteinemia (a)Germany
-
Fresenius Medical Care Deutschland GmbHCompletedHypercholesterolemia, Familial | LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIAGermany
-
Saint-Joseph UniversityUnknownDyslipidemias | LDL HyperlipoproteinemiaLebanon
-
Novartis PharmaceuticalsActive, not recruiting
-
PfizerCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IVUnited States, Canada
-
Hospices Civils de LyonCompletedHyperlipoproteinemia
-
AstraZenecaCompleted
-
Zhejiang UniversityUnknownHyperlipoproteinemiaChina
-
University of Texas Southwestern Medical CenterCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IUnited States
-
Amsterdam Molecular TherapeuticsICON plcTerminatedHyperlipoproteinemia Type ICanada
-
PfizerTerminatedHyperlipoproteinemia Type IIICanada, United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | HyperlipoproteinemiaUnited States
-
Merck Sharp & Dohme LLCCompletedHyperlipoproteinemia Type II | Hypercholesterolemia, Familial
-
UMC UtrechtErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsUnknownHyperlipoproteinemia Type III | Familial Dysbetalipoproteinemia
-
Eli Lilly and CompanyActive, not recruitingMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | HyperlipoproteinemiaUnited States, Mexico, Poland, Canada, Turkey, Japan, Argentina
-
Zhejiang UniversityCompletedHyperlipoproteinemiaChina
-
Zhejiang UniversityCompletedHyperlipoproteinemiaChina
-
Zhejiang UniversityCompletedHyperlipoproteinemia
-
University Hospital, BonnCompletedHypercholesterolemia | HyperlipoproteinemiaGermany
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
Charite University, Berlin, GermanyWithdrawnHyperlipoproteinemia(a) | Progressive Cardiovascular DiseaseGermany
-
Merck Sharp & Dohme LLCTerminatedHyperlipoproteinemia Type II | Homozygous Familial Hypercholesterolemia
-
Yonsei UniversityDaewoong Pharmaceutical Co. LTD.RecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaKorea, Republic of
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | Coronary Disease | Hyperlipidemia, Familial Combined | Hyperlipoproteinemia Type iv
-
Catabasis PharmaceuticalsCompletedHypertriglyceridemia | Hyperlipoproteinemia Type I | Lipoprotein Lipase Deficiency, Familial | Chylomicronemia, FamilialCanada